Previous 10 | Next 10 |
home / stock / dgnof / dgnof news
BROSSARD, Quebec, Oct. 28, 2021 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ” or “the Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces that its AI platform has delivered wor...
BROSSARD, Quebec, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or “the Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces it will be featured on CEO Clips on t...
BROSSARD, Quebec, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or “the Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces the signing of a 7-year contract with...
BROSSARD, Quebec, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or “the Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces the signing of a 3-year contract with...
BROSSARD, Quebec, Sept. 02, 2021 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ” or “the Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of certain critical health issues, announces today a contract renewal to provide i...
BROSSARD, Quebec, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues, announces that the 2021 annual general and special meeting of shareholders (...
BROSSARD, Quebec, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce that it has entered into a Memor...
BROSSARD, Quebec, July 28, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a pilot in Spain with th...
BROSSARD, Quebec, July 22, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the official opening of the init...
BROSSARD, Quebec, July 20, 2021 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ” or the “ Company ”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues, announces today the initiation of a clinical trial study with Commo...
News, Short Squeeze, Breakout and More Instantly...
BROSSARD, Quebec, May 21, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through its FL AI RE platform based on Artificial Intelligence ( AI ), is ...
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...